PMID- 27997139 OWN - NLM STAT- MEDLINE DCOM- 20170717 LR - 20211204 IS - 1520-5010 (Electronic) IS - 0893-228X (Print) IS - 0893-228X (Linking) VI - 30 IP - 2 DP - 2017 Feb 20 TI - Isotope Dilution nanoLC/ESI(+)-HRMS(3) Quantitation of Urinary N7-(1-Hydroxy-3-buten-2-yl) Guanine Adducts in Humans and Their Use as Biomarkers of Exposure to 1,3-Butadiene. PG - 678-688 LID - 10.1021/acs.chemrestox.6b00407 [doi] AB - 1,3-Butadiene (BD) is an important industrial and environmental chemical classified as a known human carcinogen. Occupational exposure to BD in the polymer and monomer industries is associated with an increased incidence of lymphoma. BD is present in automobile exhaust, cigarette smoke, and forest fires, raising concern about potential exposure of the general population to this carcinogen. Following inhalation exposure, BD is bioactivated to 3,4-epoxy-1-butene (EB). If not detoxified, EB is capable of modifying guanine and adenine bases of DNA to form nucleobase adducts, which interfere with accurate DNA replication and cause cancer-initiating mutations. We have developed a nanoLC/ESI(+)-HRMS(3) methodology for N7-(1-hydroxy-3-buten-2-yl) guanine (EB-GII) adducts in human urine (limit of detection: 0.25 fmol/mL urine; limit of quantitation: 1.0 fmol/mL urine). This new method was successfully used to quantify EB-GII in urine of F344 rats treated with 0-200 ppm of BD, occupationally exposed workers, and smokers belonging to two different ethnic groups. EB-GII amounts increased in a dose-dependent manner in urine of laboratory rats exposed to 0, 62.5, or 200 ppm of BD. Urinary EB-GII levels were significantly increased in workers occupationally exposed to 0.1-2.2 ppm of BD (1.25 +/- 0.51 pg/mg of creatinine) as compared to administrative controls exposed to <0.01 ppm of BD (0.22 +/- 0.08 and pg/mg of creatinine) (p = 0.0024), validating the use of EB-GII as a biomarker of human exposure to BD. EB-GII was also detected in smokers' urine with European American smokers excreting significantly higher amounts of EB-GII than African American smokers (0.48 +/- 0.09 vs 0.12 +/- 0.02 pg/mg of creatinine, p = 3.1 x 10(-7)). Interestingly, small amounts of EB-GII were observed in animals and humans with no known exposure to BD, providing preliminary evidence for its endogenous formation. Urinary EB-GII adduct levels and urinary mercapturic acids of BD (MHBMA, DHBMA) were compared in a genotyped multiethnic smoker cohort. FAU - Sangaraju, Dewakar AU - Sangaraju D FAU - Boldry, Emily J AU - Boldry EJ FAU - Patel, Yesha M AU - Patel YM AD - Division of Biostatistics, Keck School of Medicine and Children's Cancer Group, University of Southern California , Los Angeles, California 90089, United States. FAU - Walker, Vernon AU - Walker V AD - Department of Pathology and Laboratory Medicine, University of Vermont , Burlington, Vermont 05405, United States. FAU - Stepanov, Irina AU - Stepanov I AUID- ORCID: 0000-0001-5140-8944 FAU - Stram, Daniel AU - Stram D AD - Division of Biostatistics, Keck School of Medicine and Children's Cancer Group, University of Southern California , Los Angeles, California 90089, United States. FAU - Hatsukami, Dorothy AU - Hatsukami D FAU - Tretyakova, Natalia AU - Tretyakova N AUID- ORCID: 0000-0002-0621-6860 LA - eng GR - P01 CA138338/CA/NCI NIH HHS/United States GR - P30 CA077598/CA/NCI NIH HHS/United States PT - Journal Article PT - Validation Study DEP - 20170117 PL - United States TA - Chem Res Toxicol JT - Chemical research in toxicology JID - 8807448 RN - 0 (Biomarkers) RN - 0 (Butadienes) RN - 0 (N-7-(1-hydroxy-3-buten-2-yl)guanine) RN - 5Z93L87A1R (Guanine) RN - JSD5FGP5VD (1,3-butadiene) SB - IM MH - Animals MH - Biomarkers/*urine MH - Butadienes/*toxicity MH - Chromatography, High Pressure Liquid MH - Ethnicity MH - Guanine/urine MH - Humans MH - Indicator Dilution Techniques MH - Mass Spectrometry/*methods MH - Rats MH - Rats, Inbred F344 MH - Reproducibility of Results MH - Spectrometry, Mass, Electrospray Ionization/*methods PMC - PMC5515386 MID - NIHMS874818 COIS- Notes The authors declare no competing financial interest. EDAT- 2016/12/21 06:00 MHDA- 2017/07/18 06:00 PMCR- 2017/08/20 CRDT- 2016/12/21 06:00 PHST- 2016/12/21 06:00 [pubmed] PHST- 2017/07/18 06:00 [medline] PHST- 2016/12/21 06:00 [entrez] PHST- 2017/08/20 00:00 [pmc-release] AID - 10.1021/acs.chemrestox.6b00407 [doi] PST - ppublish SO - Chem Res Toxicol. 2017 Feb 20;30(2):678-688. doi: 10.1021/acs.chemrestox.6b00407. Epub 2017 Jan 17.